in compliance with chapter 10a of Directive 2013/34/EU ('country-by-country reporting')
| Name of ultimate parent of group / of standalone company |
|
|---|---|
| Country of registered office of ultimate parent undertaking |
|
| Date of start of financial year |
|
| Date of end of financial year |
|
| Reporting currency |
|
| Language of report |
|
| Application of option to report in accordance with taxation reporting instructions |
|
| Name and registered office of a single subsidiary undertaking which has published the report on income tax information of an undertaking that is not governed by the law of a Member State |
|
| Name and address of a single branch which has published the report on income tax information of an undertaking that is not governed by the law of a Member State | - |
| Tax jurisdiction | Country code of Member State or tax jurisdiction | Revenue | Profit (loss) before tax | Income tax paid (on cash basis) | Income tax accrued | Accumulated earnings | Number of employees |
|---|---|---|---|---|---|---|---|
| Belgium |
|
|
- |
|
|
|
|
| Czechia |
|
|
- |
|
|
|
|
| France |
|
|
|
|
|
|
|
| Germany |
|
|
|
|
|
|
|
| Ireland |
|
|
- |
|
|
|
|
| Italy |
|
|
|
|
|
|
|
| Netherlands |
|
|
|
|
|
|
|
| Norway |
|
|
|
|
|
|
|
| Portugal |
|
|
- |
|
|
|
|
| Spain |
|
|
|
|
|
|
|
| Sweden |
|
|
|
|
|
|
|
| Turkey |
|
|
|
|
|
|
|
| Vietnam |
|
|
- |
|
|
|
|
| All other tax jurisdictions (aggregated basis) | - |
|
|
|
|
|
|
| Tax jurisdiction | Country code of Member State or tax jurisdiction | Names of subsidiary undertakings | Brief description of nature of activities |
|---|---|---|---|
| Belgium |
|
ReCor Medical, Ltd.; Nutrition & Sante Benelux S.A. |
Sales, Marketing or Distribution |
| Czechia |
|
Interpharma Praha, a.s. |
Research and Development; Manufacturing or Production; Sales, Marketing or Distribution |
| France |
|
Euriso-Top SAS; Nutrition & Sante SAS; Nardobel SAS; Otsuka Pharmaceutical France SAS |
Research and Development; Holding or Managing Intellectual Property; Manufacturing or Production; Sales, Marketing or Distribution; Administrative, Management or Support Services; Holding shares or other equity instruments |
| Germany |
|
Otsuka Novel Products GmbH; Otsuka Holdings Europe GmbH; Recor Medical Europe GmbH; Otsuka Pharma GmbH; Euriso-Top GmbH; Otsuka Pharmaceutical Development & Commercialisation Europe GmbH; Advanced Biochemical Compounds GmbH; Cambridge Isotope Laboratories (Europe) GmbH |
Research and Development; Manufacturing or Production; Sales, Marketing or Distribution; Administrative, Management or Support Services; Holding shares or other equity instruments |
| Ireland |
|
Veryan Medical Ltd (Irish branch) |
Manufacturing or Production |
| Italy |
|
Nutrition & Sante Italia SpA; Otsuka Pharmaceutical Italy S.r.l. |
Manufacturing or Production; Sales, Marketing or Distribution |
| Netherlands |
|
Taiho Pharma Netherlands B.V.; ReCor Medical BV; Otsuka Pharmaceutical Netherlands BV; Nutrition & Sante Benelux S.A. |
Sales, Marketing or Distribution; Dormant |
| Norway |
|
Otsuka Pharma Scandinavia AB |
Sales, Marketing or Distribution |
| Portugal |
|
Biocentury Portugal, Unipessoal Lda.; Otsuka Pharmaceutical Portugal, Unipessoal Lda |
Sales, Marketing or Distribution |
| Spain |
|
Nutrition & Sante Iberia SL; Hebron S.A.; Trocellen Iberica S.A.; Otsuka Pharmaceutical, S.A. |
Manufacturing or Production; Sales, Marketing or Distribution |
| Sweden |
|
Otsuka Pharma Scandinavia AB |
Sales, Marketing or Distribution |
| Turkey |
|
Abdi Ibrahim Otsuka Ilac San. Ve Tic. A.S. / Abdi Ibrahim Otsuka Pharmaceutical Company |
Manufacturing or Production; Sales, Marketing or Distribution |
| Vietnam |
|
Otsuka Nutraceutical Vietnam Co., Ltd.; Otsuka Techno Vietnam Co., Ltd.; Otsuka Pharmaceutical Vietnam Joint Stock Company |
Manufacturing or Production; Sales, Marketing or Distribution |